<qa>  What is the SYNTHETIC LONG PEPTIDE BREAST CANCERSAFETY AND IMMUNOGENICITY OF A PERSONALIZED SYNTHETIC LONG PEPTIDE BREAST CANCER VACCINE STRATEGY IN PATIENTS WITH PERSISTENT TRIPLE-NEGATIVE BREAST CANCER FOLLOWING NEOADJUVANT CHEMOTHERAPY: 